International Assets Investment Management LLC Sells 851,186 Shares of Stryker Co. (NYSE:SYK)

International Assets Investment Management LLC lowered its holdings in Stryker Co. (NYSE:SYK - Free Report) by 99.7% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 2,583 shares of the medical technology company's stock after selling 851,186 shares during the quarter. International Assets Investment Management LLC's holdings in Stryker were worth $927,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also bought and sold shares of the stock. Dunhill Financial LLC lifted its position in Stryker by 94.9% in the third quarter. Dunhill Financial LLC now owns 76 shares of the medical technology company's stock worth $27,000 after purchasing an additional 37 shares during the period. Centennial Bank AR lifted its holdings in shares of Stryker by 106.7% during the 2nd quarter. Centennial Bank AR now owns 93 shares of the medical technology company's stock worth $32,000 after acquiring an additional 48 shares during the period. Darwin Wealth Management LLC acquired a new stake in shares of Stryker during the 3rd quarter valued at about $36,000. HBW Advisory Services LLC bought a new stake in Stryker in the third quarter valued at about $42,000. Finally, Hara Capital LLC bought a new position in Stryker during the third quarter worth about $42,000. Institutional investors own 77.09% of the company's stock.

Wall Street Analyst Weigh In

SYK has been the topic of several analyst reports. Canaccord Genuity Group upped their price objective on Stryker from $360.00 to $400.00 and gave the company a "buy" rating in a research note on Wednesday, October 30th. Wells Fargo & Company upped their price target on Stryker from $405.00 to $427.00 and gave the company an "overweight" rating in a research report on Wednesday, December 11th. Needham & Company LLC reissued a "buy" rating and set a $442.00 price objective on shares of Stryker in a report on Tuesday. JPMorgan Chase & Co. increased their target price on shares of Stryker from $375.00 to $420.00 and gave the stock an "overweight" rating in a research report on Wednesday, October 30th. Finally, BTIG Research boosted their price target on shares of Stryker from $383.00 to $394.00 and gave the company a "buy" rating in a research report on Wednesday, October 30th. Four investment analysts have rated the stock with a hold rating and eighteen have assigned a buy rating to the company. According to MarketBeat.com, Stryker has a consensus rating of "Moderate Buy" and a consensus target price of $405.80.

Stryker Trading Up 0.5 %

Shares of SYK stock traded up $1.94 on Friday, hitting $366.04. The stock had a trading volume of 1,313,772 shares, compared to its average volume of 1,285,595. The firm has a market cap of $139.54 billion, a P/E ratio of 39.23, a PEG ratio of 2.82 and a beta of 0.95. Stryker Co. has a twelve month low of $306.10 and a twelve month high of $398.20. The company has a current ratio of 1.91, a quick ratio of 1.22 and a debt-to-equity ratio of 0.66. The company has a fifty day moving average price of $375.42 and a two-hundred day moving average price of $357.51.

Stryker (NYSE:SYK - Get Free Report) last posted its earnings results on Tuesday, October 29th. The medical technology company reported $2.87 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.77 by $0.10. The business had revenue of $5.49 billion during the quarter, compared to analysts' expectations of $5.37 billion. Stryker had a return on equity of 23.07% and a net margin of 16.34%. Stryker's revenue for the quarter was up 11.9% compared to the same quarter last year. During the same period in the prior year, the business earned $2.46 EPS. As a group, analysts forecast that Stryker Co. will post 12.06 earnings per share for the current fiscal year.

Stryker Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Tuesday, December 31st will be given a $0.84 dividend. This represents a $3.36 dividend on an annualized basis and a yield of 0.92%. The ex-dividend date is Tuesday, December 31st. This is a positive change from Stryker's previous quarterly dividend of $0.80. Stryker's dividend payout ratio (DPR) is currently 36.01%.

Insider Buying and Selling at Stryker

In related news, CEO Kevin Lobo sold 57,313 shares of Stryker stock in a transaction dated Thursday, November 7th. The stock was sold at an average price of $368.70, for a total value of $21,131,303.10. Following the sale, the chief executive officer now owns 100,027 shares of the company's stock, valued at approximately $36,879,954.90. The trade was a 36.43 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 5.50% of the company's stock.

Stryker Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.